Objective To study the impact of Gx on quantification of hepatic fat contents under metabolic dysfunction-associated steatotic liver disease (MASLD) imaged on VIBE Dixon in hepatobiliary specific phase. Methods Forty-two rabbits were randomly divided into control group ( n = 10) and high-fat diet group ( n = 32). Imaging was performed before enhancement (Pre-Gx) and at the 13th (Post-Gx13) and 17th (Post-Gx17) min after Gx enhancement with 2E- and 6E-VIBE Dixon to determine hepatic proton density fat fractions (PDFF). PDFFs were compared with vacuole percentage (VP) measured under histopathology. Results 33 animals were evaluated and including control group ( n = 11) and MASLD group ( n = 22). Pre-Gx, Post-Gx13, Post-Gx17 PDFFs under 6E-VIBE Dixon had strong correlations with VPs ( r 2 = 0.8208—0.8536). PDFFs under 2E-VIBE Dixon were reduced significantly ( P < 0.001) after enhancement ( r 2 = 0.7991/0.8014) compared with that before enhancement ( r 2 = 0.7643). There was no significant difference between PDFFs of Post-Gx13 and Post-Gx17 ( P = 0.123) for which the highest consistency being found with 6E-VIBE Dixon before enhancement ( r 2 = 0.8536). The signal intensity of the precontrast compared with the postcontrast, water image under 2E-VIBE Dixon increased significantly ( P < 0.001), fat image showed no significant difference ( P = 0.754). Conclusion 2E- and 6E-VIBE Dixon can obtain accurate PDFFs in the hepatobiliary specific phase from 13 to 17th min after Gx enhancement. On 2E-VIBE Dixon (FA = 10°), effective minimization of T1 Bias by the Gx administration markedly improved the accuracy of the hepatic PDFF quantification.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: